KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors — TORC1/2 Inhibition as Salvage Strategy
2019 | journal article. A publication with affiliation to the University of Göttingen.
Jump to: Cite & Linked | Documents & Media | Details | Version history
Cite this publication
KIT-Dependent and KIT-Independent Genomic Heterogeneity of Resistance in Gastrointestinal Stromal Tumors — TORC1/2 Inhibition as Salvage Strategy
Mühlenberg, T.; Ketzer, J.; Heinrich, M. C.; Grunewald, S.; Marino-Enriquez, A.; Trautmann, M. & Hartmann, W. et al. (2019)
Molecular Cancer Therapeutics, 18(11) pp. 1985-1996. DOI: https://doi.org/10.1158/1535-7163.MCT-18-1224
Documents & Media
Details
- Authors
- Mühlenberg, Thomas; Ketzer, Julia; Heinrich, Michael C.; Grunewald, Susanne; Marino-Enriquez, Adrian; Trautmann, Marcel; Hartmann, Wolfgang; Wardelmann, Eva; Treckmann, Jürgen; Worm, Karl; Bertram, Stefanie; Herold, Thomas; Schildhaus, Hans-Ulrich ; Glimm, Hanno; Stenzinger, Albrecht; Brors, Benedikt; Horak, Peter; Hohenberger, Peter; Fröhling, Stefan; Fletcher, Jonathan A.; Bauer, Sebastian
- Issue Date
- 2019
- Journal
- Molecular Cancer Therapeutics
- ISSN
- 1535-7163
- eISSN
- 1538-8514
- Language
- English
